Status:

TERMINATED

Development and Validation of a Model to Predict Fast Progression in Glaucoma

Lead Sponsor:

Duke University

Collaborating Sponsors:

Genentech, Inc.

Conditions:

Glaucoma

Primary Open Angle Glaucoma

Eligibility:

All Genders

40-90 years

Brief Summary

1. The purpose of this study is to obtain genetic data on a well-defined population of patients with glaucoma that had accurate measurements of rates of structural and functional change over time. 2. ...

Detailed Description

The purpose of this study is to obtain genetic data on a well-defined population of patients with glaucoma that had accurate measurements of rates of structural and functional change over time, develo...

Eligibility Criteria

Inclusion

  • Phase I:
  • Inclusion Criteria:
  • 1\. Subjects will be identified from a previous database search (PRO00103899) with glaucoma or suspicion of glaucoma based on International Classification of Diseases (ICD) codes at baseline.
  • Phase II:
  • Inclusion criteria:
  • Subjects must be between the ages of 40 and 90 years old;
  • Both males and females will be included.
  • Be able and willing to provide signed informed consent and follow study instructions
  • Exclusion criteria:
  • Subjects will be excluded if they present with any systemic or ocular conditions that in the opinion of the Principal Investigator may prevent them from completing the tests (e.g. history of seizures or pathologies affecting the vestibular system or lower limbs).
  • Women of child-bearing potential will be excluded from tests that require pupil dilation, unless they have already received dilating drops as part of their standard of care.

Exclusion

    Key Trial Info

    Start Date :

    July 20 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    April 24 2023

    Estimated Enrollment :

    1152 Patients enrolled

    Trial Details

    Trial ID

    NCT04454190

    Start Date

    July 20 2021

    End Date

    April 24 2023

    Last Update

    March 25 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Duke University Eye Center

    Durham, North Carolina, United States, 27705